Only eight seats remain

for the Digiday Programmatic Marketing Summit, May 6-8 in Palm Springs.

SECURE YOUR SEAT

Brave, an ad-banishing browser, aims to block the Internet’s ‘greed and ugliness’

A Web browser that zaps ads only to replace them with more ads sounds counterproductive, but not to Mozilla co-founder and JavaScript creator Brendan Eich.

He’s built Brave, a new browser released in beta that “blocks all the greed and ugliness” on the Internet by automatically blocking slow-loading and privacy-invading ads by default and replaces them with approved ads.

The “Web today faces a primal threat” in the form of ad-blocking, Eich writes. While ad-blockers makes the Internet experience better, he says it feels like “free-riding, or even starting a war,” referring to Marco Arment’s ad-blocker app that was pulled from the Apple Store just a few days after its release.

Enter Brave. It’s a browser that blocks privacy-invading ads, malware and trackers and uses the company’s own safe ads. The plan is to convince brands and publishers to uses Brave’s ad-tech platform then splits revenue between itself and advertisers.

Brave released a video showing the browser in action, as seen below. On the left, is Apple’s Safari, where ads clog the usability of the Internet, and on the right is Brave, where pages load four times faster.

So far, Brave hasn’t signed up any advertisers but Eich said is working with “one of the big ad agencies” to pilot the browser.

More in Marketing

Puma’s AI head says the brand is still giving ‘the keys to the consumer’ as it invests in digital concierge

Puma , this month, debuted a new AI-powered “digital human” concierge named “Dylan” in its Las Vegas flagship.

The Rundown: Q1 dealmaking cools across ad tech and martech as AI remains the hottest ticket

LUMA Partners’ Q1 report notes the drag that macroeconomic uncertainty has had on dealmaking.

‘Everything is coming down’: ChatGPT ads are getting cheaper

While the pilot CPM started out at $60, advertisers are now seeing that price drop to as low as $25, just nine weeks into the test.